Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Change in Cash (2016 - 2025)

Historic Change in Cash for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to -$15.6 million.

  • Aspen Aerogels' Change in Cash fell 17056.27% to -$15.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.5 million, marking a year-over-year increase of 10374.74%. This contributed to the annual value of $81.3 million for FY2024, which is 15702.01% up from last year.
  • According to the latest figures from Q3 2025, Aspen Aerogels' Change in Cash is -$15.6 million, which was down 17056.27% from -$24.4 million recorded in Q2 2025.
  • Aspen Aerogels' 5-year Change in Cash high stood at $180.2 million for Q4 2022, and its period low was -$74.4 million during Q1 2023.
  • Moreover, its 5-year median value for Change in Cash was -$15.6 million (2025), whereas its average is $7.2 million.
  • The largest annual percentage gain for Aspen Aerogels' Change in Cash in the last 5 years was 1768879.67% (2022), contrasted with its biggest fall of 78889.38% (2022).
  • Aspen Aerogels' Change in Cash (Quarter) stood at -$19.0 million in 2021, then surged by 1049.88% to $180.2 million in 2022, then crashed by 75.02% to $45.0 million in 2023, then surged by 138.61% to $107.4 million in 2024, then plummeted by 114.53% to -$15.6 million in 2025.
  • Its Change in Cash stands at -$15.6 million for Q3 2025, versus -$24.4 million for Q2 2025 and -$28.8 million for Q1 2025.